Targeted cancer drugs are widely used because of their ability to inhibit specific proteins involved in cancer development with fewer side effects compared to chemotherapy drugs. But targeted therapies can often inhibit other ...
Oct 16, 2023
0
27
Cutaneous squamous cell carcinoma is the second most common type of skin cancer in the United States, impacting approximately 700,000 people each year. While medications exist to prevent the development of disease, they are ...
Oct 11, 2023
0
24
Most cancer deaths are due to the metastatic spread and growth of tumor cells at distant sites. Identifying appropriate treatments for patients with metastatic disease is challenging because of limited biomarkers and detection ...
Aug 15, 2023
0
7
One in eight women will develop breast cancer in their lifetime. The disease is treatable, especially when caught early. But what is the impact of breast cancer later in life? A Moffitt Cancer Center researcher, in collaboration ...
Jul 19, 2023
0
26
Cancer treatment can be physically, mentally and emotionally taxing. Patients report disruptions in sleep and physical activity, as well as fatigue and depression. Strategies to manage or inhibit these treatment related symptoms ...
Jul 5, 2023
0
0
Prostate cancer frequently metastasizes to the bone and is incurable. Moffitt Cancer Center researchers are working to identify new treatment options for this subset of patients. In a new article published today in Science ...
May 3, 2023
0
33
Outcomes for patients with clear cell renal cell carcinoma have improved over the past decade due to the approval of immunotherapies, yet still there is a subset of patients who do not respond to this type of therapy.
Apr 26, 2023
0
24
MYC proteins are important regulators of cancer cell growth, proliferation and metabolism through their ability to increase the expression of proteins involved in these processes. Deregulation of MYC proteins occurs in more ...
Apr 20, 2023
0
4
Immunotherapies have greatly improved the outcomes of many patients with melanoma. But there is still a need for new approaches for the subset of patients who do not respond well to this type of therapy. Moffitt Cancer Center ...
Mar 27, 2023
0
57
Tobacco use is the leading preventable cause of death in the U.S., accounting for about 1 in 5 deaths each year. It is also a risk factor for the development of cervical cancer and precancerous stages of cervical cancer. ...
Mar 16, 2023
0
2
